Rossari Biotech Ltd

AI
Rossari Biotech Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Rossari Biotech Ltd

₹ 417 -4.71%
21 Oct - close price
rossari.com BSE: 543213 NSE: ROSSARI
About

Rossari Biotech was started in 2003.
They are among the largest manufacturers
of textile specialty chemicals in India.[1]

Key Points

Product Segments:[1]
The company is one of India’s leading specialty chemicals manufacturer offering 4,280+ products across 3 verticals:

Website BSE NSE
  • Market Cap ₹ 2,305 Cr.
  • Current Price ₹ 417
  • High / Low ₹ 663 / 373
  • Stock P/E 15.1
  • Book Value ₹ 254
  • Dividend Yield 0.12 %
  • ROCE 13.3 %
  • ROE 10.8 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company's working capital requirements have reduced from 62.4 days to 48.6 days

Cons

  • Company has a low return on equity of 12.0% over last 3 years.
  • Dividend payout has been low at 2.00% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Part of BSE Commodities BSE 1000

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
483 464 473 490 498 513 580 544 586 582 685 697 698
420 400 409 425 432 448 510 476 514 513 608 617 611
Operating Profit 64 64 64 65 66 65 69 68 72 69 77 81 87
OPM % 13% 14% 13% 13% 13% 13% 12% 12% 12% 12% 11% 12% 12%
1 4 1 1 1 1 2 2 2 1 20 4 1
Interest 5 4 3 4 4 5 6 6 6 8 9 11 9
Depreciation 15 15 16 15 15 18 18 18 18 20 24 26 30
Profit before tax 45 48 46 47 48 42 48 46 50 43 64 48 49
Tax % 26% 28% 25% 26% 27% 25% 28% 27% 26% 23% 28% 26% 21%
33 34 34 35 35 32 34 34 37 33 46 35 39
EPS in Rs 5.97 6.23 6.18 6.32 6.39 5.73 6.22 6.07 6.66 5.92 8.30 6.34 7.02
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
516 600 709 1,483 1,656 1,831 2,080 2,396 2,661
438 495 586 1,299 1,433 1,581 1,815 2,110 2,348
Operating Profit 78 105 124 184 223 250 265 286 314
OPM % 15% 17% 17% 12% 13% 14% 13% 12% 12%
1 4 9 13 6 8 5 24 25
Interest 3 4 3 13 22 19 18 29 36
Depreciation 12 17 23 48 63 60 67 79 99
Profit before tax 63 88 107 136 144 178 185 203 204
Tax % 28% 26% 25% 28% 26% 26% 26% 26%
46 65 80 98 107 131 136 149 153
EPS in Rs 9.44 12.86 15.45 17.74 19.45 23.66 24.63 26.94 27.58
Dividend Payout % 0% 4% 3% 3% 3% 2% 2% 2%
Compounded Sales Growth
10 Years: %
5 Years: 28%
3 Years: 13%
TTM: 20%
Compounded Profit Growth
10 Years: %
5 Years: 11%
3 Years: 8%
TTM: 12%
Stock Price CAGR
10 Years: %
5 Years: -22%
3 Years: -20%
1 Year: -36%
Return on Equity
10 Years: %
5 Years: 13%
3 Years: 12%
Last Year: 11%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Equity Capital 4 10 10 11 11 11 11 11 11
Reserves 119 277 398 794 904 1,037 1,174 1,322 1,397
8 67 0 8 74 119 218 436 388
118 118 152 442 375 401 482 505 564
Total Liabilities 250 471 561 1,255 1,364 1,567 1,886 2,274 2,359
74 94 181 607 585 578 598 784 845
CWIP 3 22 0 1 16 47 140 173 156
Investments 0 18 0 36 51 63 84 62 30
173 338 379 611 712 880 1,063 1,254 1,328
Total Assets 250 471 561 1,255 1,364 1,567 1,886 2,274 2,359

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
71 57 48 29 152 43 137 65
-37 -190 -37 -299 -181 -103 -183 -220
-29 157 -25 292 61 16 65 186
Net Cash Flow 5 23 -14 22 32 -44 19 31
Free Cash Flow 27 -19 -8 -7 120 -83 -21 -175
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 118% 74% 64% 43% 89% 39% 74% 47%

Ratios

Consolidated / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 61 57 74 75 78 85 83 85
Inventory Days 59 57 75 63 59 80 90 88
Days Payable 114 95 104 61 56 62 73 71
Cash Conversion Cycle 6 19 46 76 80 103 101 103
Working Capital Days 23 22 60 62 49 70 69 49
ROCE % 38% 29% 24% 18% 18% 16% 13%

Insights

In beta
Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Installed Capacity
MTPA

Log in to view insights

Please log in to see hidden values.

Login
Number of Customers
customers
Number of Countries Exported To
countries
Number of Products
products
Export Revenue
Rs. crore
AHN Segment Revenue
Rs. crore
HPPC Segment Revenue
Rs. crore
TSC Segment Revenue
Rs. crore

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
68.34% 68.32% 68.32% 68.27% 68.19% 68.18% 68.18% 68.18% 68.15% 68.15% 68.14% 68.14%
4.14% 4.02% 3.83% 3.74% 3.74% 3.98% 3.48% 2.70% 2.32% 2.18% 2.03% 1.84%
18.06% 17.74% 16.87% 17.34% 17.47% 17.59% 17.84% 18.18% 18.25% 18.21% 14.64% 14.19%
9.45% 9.90% 10.98% 10.64% 10.60% 10.24% 10.50% 10.95% 11.25% 11.46% 15.19% 15.84%
No. of Shareholders 1,00,42398,8591,00,47597,18895,73592,85291,79191,38789,24986,97287,58086,622

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls